Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain
- Conditions
- NeuralgiaNeuralgia; PostherpeticDiabetic Neuropathy, PainfulFailed Back Surgery Syndrome
- Interventions
- Procedure: Electroacupuncture
- Registration Number
- NCT03315598
- Lead Sponsor
- Seoul National University
- Brief Summary
The investigators will evaluate the effectiveness and safety of acupuncture treatment in refractory neuropathic pain patients.
- Detailed Description
The purpose of this study was to evaluate the effectiveness of acupuncture treatment in the patients with the following neuropathic pain related syndrome.
* Postherpetic neuralgia
* Failed back surgery syndrome
* Diabetic neuropathy
* other peripheral neuropathy
Patients with refractory neuropathic pain who do not respond to conservative treatment for more than 3 months should be included. Acupuncture treatment is maintained for 2 months in oriental medicine hospital. The effect is evaluated through the numeric rating score and the validated questionnaire.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 22
- Patients who can adequately write a reportable questionnaire
- Patients who have been diagnosed with one of the following neuropathic pain disease (postherpetic neuralgia, failed back surgery syndrome, diabetic neuropathy, other peripheral neuropathy)
- Patients who failed conservative treatment at Seoul National University Hospital for more than 3 months.
- Patients with NRS 5 points or more
- Patients with painDETECT score 19 points or more
- Patients with major mental illness
- Patients with unstable medical conditions
- Pregnant
- Patients who received acupuncture treatment at the site within the past month
- Patients with bleeding tendency
- Patients taking immunosuppressive drugs
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description An open-labeled, single-arm, exploratory pilot study Electroacupuncture Electroacupunture for 2months
- Primary Outcome Measures
Name Time Method Change from baseline Numeric rating scale pain score (0-10) at 8 weeks At 8-week follow-up visit The Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).
Change from baseline Numeric rating scale pain score (0-10) at 4 weeks At 4-week follow-up visit The Numeric Rating Scale (NRS) is an 11-point scale from 0 to 10 for patient self-reporting of pain. Change from the baseline NRS pain score at 4 weeks will be noted as percentage (%).
- Secondary Outcome Measures
Name Time Method Change from the score of the short-form McGill Pain Questionnaire at 8 weeks At 8-week follow-up visit The main component of the SF-MPQ consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe. Three pain scores are derived from the sum of the intensity rank values of the words chosen for sensory, affective and total descriptors. The SF-MPQ also includes the Present Pain Intensity (PPI) index of the standard MPQ and a visual analogue scale (VAS).
Change from baseline score of Brief Pain Inventory Short Form (BFI-SF) at 8 weeks At 8-week follow-up visit The Brief Pain Inventory (BPI) rapidly assesses the severity of pain and its impact on functioning.
5-pointed patient satisfaction scale At 8-week follow-up visit The 5-pointed patient satisfaction scale is an 5-point scale for patient self-reporting of satisfaction with treatment.
1. Very satisfied
2. Satisfied
3. Neither satisfied nor dissatisfied
4. Dissatisfied
5. Very dissatisfiedPatients' Global Impression of Change (PGIC) scale At 8-week follow-up visit The self-report measure Patient Global Impression of Change (PGIC) reflects a patient's belief about the efficacy of treatment.
1=very much improved since the initiation of treatment; 2=much improved; 3=minimally improved; 4=no change from baseline (the initiation of treatment); 5=minimally worse; 6= much worse; 7=very much worse since the initiation of treatment.
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of